InfuSystems Holdings Inc (INFU)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX
Market Cap: $296.30M
Last updated: Nov 17, 2026 at 4:15 PM ET
InfuSystems Holdings Inc (INFU) Statistics
InfuSystems Holdings (INFU) has a market cap of $296.30M and an enterprise value of $306.87M. Its trailing P/E of 29.6x is below its 5-year median of 96.1x. Its share count is down 2.14% from a year earlier.
Total Valuation
Enterprise value is 3.57% above the market cap, as debt exceeds cash.
| Market Cap | $296.30M |
|---|---|
| Enterprise Value | $306.87M |
| Latest price (Nov 17, 2026) | $14.79 |
Key Dates
The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.0x and 4.6x. Its year-end P/E ranged from 17.9x to 868.0x from 2019 to 2025.
| P/E Ratio | 29.6x |
|---|---|
| Forward P/E | 31.5x |
| P/S Ratio | 2.0x |
| Forward P/S | 2.0x |
| P/B Ratio | 4.6x |
| P/TBV Ratio | 5.5x |
| P/FCF Ratio | 11.9x |
| P/OCF Ratio | 11.7x |
| PEG Ratio | 0.7 |
Enterprise Valuation
Counting debt and cash, the company is valued at 11.2x EBITDA and 12.4x free cash flow.
| EV / Earnings | 32.5x |
|---|---|
| EV / Sales | 2.1x |
| EV / EBITDA | 11.2x |
| EV / EBIT | 21.4x |
| EV / FCF | 12.4x |
Price Statistics
The stock is up 55.52% over 52 weeks and trades 9.64% above its 50-day average.
| Beta (1Y) | 0.82 |
|---|---|
| 52-Week Change | +55.52% |
| 1-Month Change | +7.64% |
| 3-Month Change | +21.33% |
| 6-Month Change | +52.95% |
| 5-Year Change | -15.39% |
| 10-Year Change | +451.76% |
| Total Return (1Y) | +55.52% |
| Total Return (3Y CAGR) | +16.76% |
| Total Return (5Y CAGR) | -4.35% |
| Return vs SPY (1Y) | +47.30% |
| Max Drawdown (1Y) | -23.91% |
| Max Drawdown (3Y) | -56.84% |
| Sharpe Ratio (1Y) | 0.86 |
| Correlation with SPY (1Y) | 0.21 |
| 50-Day Average | $13.49 |
| 200-Day Average | $10.68 |
| 52-Week Range | $7.29 to $15.47 |
| RSI (14 Days) | 60.0 |
| Average Volume (20 Days) | 160.19K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.68x current liabilities, and total debt is 0.31x shareholder equity.
| Current Ratio | 2.68x |
|---|---|
| Quick Ratio | 2.39x |
| Debt / Equity | 0.31x |
| Debt / EBITDA | 0.72x |
| Debt / FCF | 0.80x |
| Interest Coverage | 13.98x |
Returns and Efficiency
Return on invested capital is 12.13% over the last 12 months, against a 5-year average of 6.65%.
| Return on Equity (ROE) | 14.72% |
|---|---|
| Return on Assets (ROA) | 9.03% |
| Return on Invested Capital (ROIC) | 12.13% |
| Return on Capital Employed (ROCE) | 16.57% |
| ROE (5Y Average) | 4.06% |
| ROA (5Y Average) | 2.23% |
| ROIC (5Y Average) | 6.65% |
| Asset Turnover | 1.42x |
| Inventory Turnover | 11.47x |
| Receivables Turnover | 5.09x |
| Cash Conversion Cycle | 47 days |
Taxes
Income tax took 29.18% of pretax income over the last 12 months.
| Income Tax (TTM) | $3.89M |
|---|---|
| Effective Tax Rate | 29.18% |
Scores
INFU has an Altman Z-Score of 5.79, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 5.79 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 8 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue of $144.44M over the last 12 months is up 2.40% from the 12 months before.
| Revenue | $144.44M |
|---|---|
| Revenue Growth (YoY) | +2.40% |
| Gross Profit | $83.26M |
| Operating Income | $14.20M |
| Pretax Income | $13.33M |
| Net Income | $9.44M |
| EBITDA | $27.34M |
| EBIT | $14.36M |
| Reported EPS (TTM) | $0.50 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 61.38% of the $104.52M in total assets.
| Cash and Equivalents | $9.11M |
|---|---|
| Total Debt | $19.69M |
| Net Debt | $10.58M |
| Net Debt Per Share | $0.53 |
| Working Capital | $30.04M |
| Shareholder Equity | $64.15M |
| Book Value Per Share | $3.21 |
| Tangible Book Value | $54.12M |
| Tangible Book Per Share | $2.71 |
| Total Assets | $104.52M |
| Total Liabilities | $40.37M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $454.00K of capital spending, operating cash flow left $24.76M of free cash flow.
| Operating Cash Flow | $25.22M |
|---|---|
| Capital Expenditures | $454.00K |
| Free Cash Flow | $24.76M |
| FCF Per Share | $1.24 |
| Depreciation and Amortization | $12.98M |
| Share Repurchases | $6.27M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 9.83%, against a 5-year average of 4.19%.
| Gross Margin | 57.64% |
|---|---|
| Operating Margin | 9.83% |
| Pretax Margin | 9.23% |
| Net Margin | 6.54% |
| EBITDA Margin | 18.93% |
| EBIT Margin | 9.94% |
| FCF Margin | 17.14% |
| Gross Margin (5Y Average) | 54.13% |
| Operating Margin (5Y Average) | 4.19% |
| Net Margin (5Y Average) | 1.69% |
Growth
Revenue grew 9.28% a year over 3 years, and EPS 268.40% a year.
| Revenue Growth (3Y CAGR) | +9.28% |
|---|---|
| Revenue Growth (5Y CAGR) | +8.05% |
| EPS Growth (3Y CAGR) | +268.40% |
| EPS Growth (5Y CAGR) | -9.20% |
| FCF Growth (3Y CAGR) | +12.98% |
| FCF Growth (5Y CAGR) | +4.45% |
| Operating Income Growth (3Y CAGR) | +93.16% |
| Book Value Per Share Growth (2Y CAGR) | +6.40% |
| Tangible Book Per Share Growth (2Y CAGR) | +8.33% |
Dividends and Yields
INFU does not pay a dividend. Its free cash flow yield is 8.38%.
| Earnings Yield | 3.38% |
|---|---|
| FCF Yield | 8.38% |
| Buyback Yield | 1.67% |
| Shareholder Yield | 1.67% |
Peer Position
Against 4 similar companies, INFU has the highest P/E.
P/E RatioPeer median 23.6x
P/S RatioPeer median 1.7x
ROICPeer median -20.01%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.95%
| P/E Ratio | 29.6x vs 23.6x median |
|---|---|
| P/S Ratio | 2.0x vs 1.7x median |
| ROIC | 12.13% vs -20.01% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +2.40% vs +13.95% median |
Analyst Forecast
Consensus estimates put revenue growth at 3.63% and EPS growth at 5.83% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +3.63% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +5.83% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About INFU
What is INFU's market cap?
InfuSystems Holdings has a market cap of $296.30M. Its enterprise value, which adds debt and subtracts cash, is $306.87M.
What is INFU's P/E ratio?
InfuSystems Holdings has a trailing P/E ratio of 29.6x and a forward P/E of 31.5x.
How many shares of INFU are outstanding?
InfuSystems Holdings has 19.98M shares outstanding. The count is down 2.14% from a year earlier.
Does INFU pay a dividend?
No. InfuSystems Holdings does not pay a dividend.
How much debt does INFU have?
InfuSystems Holdings has $19.69M of total debt and $9.11M of cash and equivalents, a net debt position of $10.58M.
INFU pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors